Adam Matos, DO | |
81 Highland Ave, Salem, MA 01970-2714 | |
(978) 741-1200 | |
Not Available |
Full Name | Adam Matos |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 7 Years |
Location | 81 Highland Ave, Salem, Massachusetts |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043740855 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 272381 (Massachusetts) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | 272381 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Partners Healthcare At Home - Home Care | Waltham, MA | Home health agency |
Bayada Home Health Care, Inc | Burlington, MA | Home health agency |
North Shore Medical Center - | Salem, MA | Hospital |
Massachusetts General Hospital | Boston, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
North Shore Physicians Group Inc | 3577467224 | 488 |
News Archive
The Lancet Oncology has published results from the largest ever trial of a single melanoma treatment. The open label safety study was conducted to assess the tolerability of Zelboraf (vemurafenib), and featured 3,222 patients from across 44 countries.1 246 of these patients were from the UK.
Juventas Therapeutics, a clinical-stage regenerative medicine company developing novel therapies for cardiovascular disease, announces that the U.S. Food and Drug Administration (FDA) authorized commencement of a Phase II clinical trial evaluating the efficacy and safety of its lead product, JVS-100, for the treatment of critical limb ischemia (CLI).
Giving young children the influenza and pneumococcal vaccines together appears to increase their risk of fever, according to a study led by researchers from Columbia University Medical Center (CUMC) and the Centers for Disease Control and Prevention (CDC). However, the fever was brief, and medical care was sought for few children, supporting the routine immunization schedule for these vaccines, including the recommendation to administer them simultaneously.
Scientists have identified more than 100 genes linked to memory, opening new avenues of research to better understand memory processing in the human brain.
› Verified 3 days ago
Entity Name | North Shore Physicians Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1588606123 PECOS PAC ID: 3577467224 Enrollment ID: O20050429000668 |
News Archive
The Lancet Oncology has published results from the largest ever trial of a single melanoma treatment. The open label safety study was conducted to assess the tolerability of Zelboraf (vemurafenib), and featured 3,222 patients from across 44 countries.1 246 of these patients were from the UK.
Juventas Therapeutics, a clinical-stage regenerative medicine company developing novel therapies for cardiovascular disease, announces that the U.S. Food and Drug Administration (FDA) authorized commencement of a Phase II clinical trial evaluating the efficacy and safety of its lead product, JVS-100, for the treatment of critical limb ischemia (CLI).
Giving young children the influenza and pneumococcal vaccines together appears to increase their risk of fever, according to a study led by researchers from Columbia University Medical Center (CUMC) and the Centers for Disease Control and Prevention (CDC). However, the fever was brief, and medical care was sought for few children, supporting the routine immunization schedule for these vaccines, including the recommendation to administer them simultaneously.
Scientists have identified more than 100 genes linked to memory, opening new avenues of research to better understand memory processing in the human brain.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Adam Matos, DO 81 Highland Ave, Salem, MA 01970-2714 Ph: () - | Adam Matos, DO 81 Highland Ave, Salem, MA 01970-2714 Ph: (978) 741-1200 |
News Archive
The Lancet Oncology has published results from the largest ever trial of a single melanoma treatment. The open label safety study was conducted to assess the tolerability of Zelboraf (vemurafenib), and featured 3,222 patients from across 44 countries.1 246 of these patients were from the UK.
Juventas Therapeutics, a clinical-stage regenerative medicine company developing novel therapies for cardiovascular disease, announces that the U.S. Food and Drug Administration (FDA) authorized commencement of a Phase II clinical trial evaluating the efficacy and safety of its lead product, JVS-100, for the treatment of critical limb ischemia (CLI).
Giving young children the influenza and pneumococcal vaccines together appears to increase their risk of fever, according to a study led by researchers from Columbia University Medical Center (CUMC) and the Centers for Disease Control and Prevention (CDC). However, the fever was brief, and medical care was sought for few children, supporting the routine immunization schedule for these vaccines, including the recommendation to administer them simultaneously.
Scientists have identified more than 100 genes linked to memory, opening new avenues of research to better understand memory processing in the human brain.
› Verified 3 days ago